Review



rabbit anti human eef1e1  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 92
      Buy from Supplier

    Structured Review

    Proteintech rabbit anti human eef1e1
    Differential expression and prognostic value of <t>EEF1E1.</t> ( A ) Differential expression of EEF1E1 in TCGA-LIHC cohort, ( B ) OEP000321 cohort and ( C ) GSE14520 cohort. ( D ) Risk accumulation curve of EEF1E1 mRNA expression for early recurrence in TCGA-LIHC and ( E ) OEP000321 cohort. ( F ) Correlation between EEF1E1 mRNA expression with Rad-scores. ( G ) IHC stains image of EEF1E1 protein levels in HCC and para cancer tissues. (**** p < 0.0001).
    Rabbit Anti Human Eef1e1, supplied by Proteintech, used in various techniques. Bioz Stars score: 92/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti human eef1e1/product/Proteintech
    Average 92 stars, based on 6 article reviews
    rabbit anti human eef1e1 - by Bioz Stars, 2026-06
    92/100 stars

    Images

    1) Product Images from "CT Radiomics Combined with Metabolic-Biomarkers Enables Early Recurrence Prediction in Hepatocellular Carcinoma"

    Article Title: CT Radiomics Combined with Metabolic-Biomarkers Enables Early Recurrence Prediction in Hepatocellular Carcinoma

    Journal: Journal of Hepatocellular Carcinoma

    doi: 10.2147/JHC.S547186

    Differential expression and prognostic value of EEF1E1. ( A ) Differential expression of EEF1E1 in TCGA-LIHC cohort, ( B ) OEP000321 cohort and ( C ) GSE14520 cohort. ( D ) Risk accumulation curve of EEF1E1 mRNA expression for early recurrence in TCGA-LIHC and ( E ) OEP000321 cohort. ( F ) Correlation between EEF1E1 mRNA expression with Rad-scores. ( G ) IHC stains image of EEF1E1 protein levels in HCC and para cancer tissues. (**** p < 0.0001).
    Figure Legend Snippet: Differential expression and prognostic value of EEF1E1. ( A ) Differential expression of EEF1E1 in TCGA-LIHC cohort, ( B ) OEP000321 cohort and ( C ) GSE14520 cohort. ( D ) Risk accumulation curve of EEF1E1 mRNA expression for early recurrence in TCGA-LIHC and ( E ) OEP000321 cohort. ( F ) Correlation between EEF1E1 mRNA expression with Rad-scores. ( G ) IHC stains image of EEF1E1 protein levels in HCC and para cancer tissues. (**** p < 0.0001).

    Techniques Used: Quantitative Proteomics, Expressing

    Relation between EEF1E1 protein levels and HCC recurrence status. ( A ) IHC stains image of EEF1E1 protein levels in different recurrence risk of HCC tissues. ( B ) Statistical analysis was performed using the Chi-square test to compare the relative levels of EEF1E1 negative (EEF1E1 − ) or positive (EEF1E1 + ) between HCC with recurrence and HCC without recurrence ( p = 0.010). ( C ) Boxplot of IHC scores of EEF1E1 between non-recurrence and recurrence patients. ( D ) Risk accumulation curve of EEF1E1 protein level for early recurrence in IHC validation cohort. ( E ) Correlation between Rad-scores and EEF1E1 IHC scores.
    Figure Legend Snippet: Relation between EEF1E1 protein levels and HCC recurrence status. ( A ) IHC stains image of EEF1E1 protein levels in different recurrence risk of HCC tissues. ( B ) Statistical analysis was performed using the Chi-square test to compare the relative levels of EEF1E1 negative (EEF1E1 − ) or positive (EEF1E1 + ) between HCC with recurrence and HCC without recurrence ( p = 0.010). ( C ) Boxplot of IHC scores of EEF1E1 between non-recurrence and recurrence patients. ( D ) Risk accumulation curve of EEF1E1 protein level for early recurrence in IHC validation cohort. ( E ) Correlation between Rad-scores and EEF1E1 IHC scores.

    Techniques Used: Biomarker Discovery



    Similar Products

    sandwich elisa  (Biorbyt)
    93
    Biorbyt sandwich elisa
    Sandwich Elisa, supplied by Biorbyt, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sandwich elisa/product/Biorbyt
    Average 93 stars, based on 1 article reviews
    sandwich elisa - by Bioz Stars, 2026-06
    93/100 stars
    		  Buy from Supplier
    rabbit anti human eef1e1  (Proteintech)
    92
    Proteintech rabbit anti human eef1e1
    Differential expression and prognostic value of <t>EEF1E1.</t> ( A ) Differential expression of EEF1E1 in TCGA-LIHC cohort, ( B ) OEP000321 cohort and ( C ) GSE14520 cohort. ( D ) Risk accumulation curve of EEF1E1 mRNA expression for early recurrence in TCGA-LIHC and ( E ) OEP000321 cohort. ( F ) Correlation between EEF1E1 mRNA expression with Rad-scores. ( G ) IHC stains image of EEF1E1 protein levels in HCC and para cancer tissues. (**** p < 0.0001).
    Rabbit Anti Human Eef1e1, supplied by Proteintech, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti human eef1e1/product/Proteintech
    Average 92 stars, based on 1 article reviews
    rabbit anti human eef1e1 - by Bioz Stars, 2026-06
    92/100 stars
    		  Buy from Supplier
    aimp3  (Proteintech)
    92
    Proteintech aimp3
    Differential expression and prognostic value of <t>EEF1E1.</t> ( A ) Differential expression of EEF1E1 in TCGA-LIHC cohort, ( B ) OEP000321 cohort and ( C ) GSE14520 cohort. ( D ) Risk accumulation curve of EEF1E1 mRNA expression for early recurrence in TCGA-LIHC and ( E ) OEP000321 cohort. ( F ) Correlation between EEF1E1 mRNA expression with Rad-scores. ( G ) IHC stains image of EEF1E1 protein levels in HCC and para cancer tissues. (**** p < 0.0001).
    Aimp3, supplied by Proteintech, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/aimp3/product/Proteintech
    Average 92 stars, based on 1 article reviews
    aimp3 - by Bioz Stars, 2026-06
    92/100 stars
    		  Buy from Supplier
    eef1ε1  (Proteintech)
    92
    Proteintech eef1ε1
    Existing studies frame rocaglates as pure eIF4A/translation inhibitors. This study conceptually redefines rocaglates as translation remodelers that reprogram both the translation machinery, e.g., increasing <t>eEF1ε1</t> translational activity, as well as the translatome, including the upregulation of numerous proteins, e.g., GEF-H1, that mediate rocaglate cytotoxicity in cancer cells. As a proof of concept, GEF-H1 activates RHOA, leading to increased JNK phosphorylation and apoptotic signaling resulting in reduced cell viability.
    Eef1ε1, supplied by Proteintech, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/eef1ε1/product/Proteintech
    Average 92 stars, based on 1 article reviews
    eef1ε1 - by Bioz Stars, 2026-06
    92/100 stars
    		  Buy from Supplier
    eef1e1  (Novus Biologicals)
    90
    Novus Biologicals eef1e1
    Existing studies frame rocaglates as pure eIF4A/translation inhibitors. This study conceptually redefines rocaglates as translation remodelers that reprogram both the translation machinery, e.g., increasing <t>eEF1ε1</t> translational activity, as well as the translatome, including the upregulation of numerous proteins, e.g., GEF-H1, that mediate rocaglate cytotoxicity in cancer cells. As a proof of concept, GEF-H1 activates RHOA, leading to increased JNK phosphorylation and apoptotic signaling resulting in reduced cell viability.
    Eef1e1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/eef1e1/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    eef1e1 - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    eef1e1  (Proteintech)
    92
    Proteintech eef1e1
    Existing studies frame rocaglates as pure eIF4A/translation inhibitors. This study conceptually redefines rocaglates as translation remodelers that reprogram both the translation machinery, e.g., increasing <t>eEF1ε1</t> translational activity, as well as the translatome, including the upregulation of numerous proteins, e.g., GEF-H1, that mediate rocaglate cytotoxicity in cancer cells. As a proof of concept, GEF-H1 activates RHOA, leading to increased JNK phosphorylation and apoptotic signaling resulting in reduced cell viability.
    Eef1e1, supplied by Proteintech, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/eef1e1/product/Proteintech
    Average 92 stars, based on 1 article reviews
    eef1e1 - by Bioz Stars, 2026-06
    92/100 stars
    		  Buy from Supplier
    immunohistochemistry of eef1e1 expression in hcc  (Human Protein Atlas)
    90
    Human Protein Atlas immunohistochemistry of eef1e1 expression in hcc
    The expression <t>of</t> <t>EEF1E1</t> in <t>HCC.</t> (A) Comparing the expression of EEF1E1 in cancer and normal. (B) Comparing the expression of EEF1E1 in cancer and paracancerous. (C) The expression of EEF1E1 in HCC from Human protein Atlas.
    Immunohistochemistry Of Eef1e1 Expression In Hcc, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/immunohistochemistry of eef1e1 expression in hcc/product/Human Protein Atlas
    Average 90 stars, based on 1 article reviews
    immunohistochemistry of eef1e1 expression in hcc - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Differential expression and prognostic value of EEF1E1. ( A ) Differential expression of EEF1E1 in TCGA-LIHC cohort, ( B ) OEP000321 cohort and ( C ) GSE14520 cohort. ( D ) Risk accumulation curve of EEF1E1 mRNA expression for early recurrence in TCGA-LIHC and ( E ) OEP000321 cohort. ( F ) Correlation between EEF1E1 mRNA expression with Rad-scores. ( G ) IHC stains image of EEF1E1 protein levels in HCC and para cancer tissues. (**** p < 0.0001).

    Journal: Journal of Hepatocellular Carcinoma

    Article Title: CT Radiomics Combined with Metabolic-Biomarkers Enables Early Recurrence Prediction in Hepatocellular Carcinoma

    doi: 10.2147/JHC.S547186

    Figure Lengend Snippet: Differential expression and prognostic value of EEF1E1. ( A ) Differential expression of EEF1E1 in TCGA-LIHC cohort, ( B ) OEP000321 cohort and ( C ) GSE14520 cohort. ( D ) Risk accumulation curve of EEF1E1 mRNA expression for early recurrence in TCGA-LIHC and ( E ) OEP000321 cohort. ( F ) Correlation between EEF1E1 mRNA expression with Rad-scores. ( G ) IHC stains image of EEF1E1 protein levels in HCC and para cancer tissues. (**** p < 0.0001).

    Article Snippet: The main steps were as follows: rabbit anti-human EEF1E1 (Proteintech Cat No: 10805-1-AP, 1:200 dilution) was incubated at 4°C overnight, followed by incubation with horseradish peroxidase (HRP)-conjugated secondary antibody (ZSGB-BIO, ZB-2301) for one h at 37°C, and staining with 3,3-diaminobenzidine tetrahydrochloride (DAB).

    Techniques: Quantitative Proteomics, Expressing

    Relation between EEF1E1 protein levels and HCC recurrence status. ( A ) IHC stains image of EEF1E1 protein levels in different recurrence risk of HCC tissues. ( B ) Statistical analysis was performed using the Chi-square test to compare the relative levels of EEF1E1 negative (EEF1E1 − ) or positive (EEF1E1 + ) between HCC with recurrence and HCC without recurrence ( p = 0.010). ( C ) Boxplot of IHC scores of EEF1E1 between non-recurrence and recurrence patients. ( D ) Risk accumulation curve of EEF1E1 protein level for early recurrence in IHC validation cohort. ( E ) Correlation between Rad-scores and EEF1E1 IHC scores.

    Journal: Journal of Hepatocellular Carcinoma

    Article Title: CT Radiomics Combined with Metabolic-Biomarkers Enables Early Recurrence Prediction in Hepatocellular Carcinoma

    doi: 10.2147/JHC.S547186

    Figure Lengend Snippet: Relation between EEF1E1 protein levels and HCC recurrence status. ( A ) IHC stains image of EEF1E1 protein levels in different recurrence risk of HCC tissues. ( B ) Statistical analysis was performed using the Chi-square test to compare the relative levels of EEF1E1 negative (EEF1E1 − ) or positive (EEF1E1 + ) between HCC with recurrence and HCC without recurrence ( p = 0.010). ( C ) Boxplot of IHC scores of EEF1E1 between non-recurrence and recurrence patients. ( D ) Risk accumulation curve of EEF1E1 protein level for early recurrence in IHC validation cohort. ( E ) Correlation between Rad-scores and EEF1E1 IHC scores.

    Article Snippet: The main steps were as follows: rabbit anti-human EEF1E1 (Proteintech Cat No: 10805-1-AP, 1:200 dilution) was incubated at 4°C overnight, followed by incubation with horseradish peroxidase (HRP)-conjugated secondary antibody (ZSGB-BIO, ZB-2301) for one h at 37°C, and staining with 3,3-diaminobenzidine tetrahydrochloride (DAB).

    Techniques: Biomarker Discovery

    Existing studies frame rocaglates as pure eIF4A/translation inhibitors. This study conceptually redefines rocaglates as translation remodelers that reprogram both the translation machinery, e.g., increasing eEF1ε1 translational activity, as well as the translatome, including the upregulation of numerous proteins, e.g., GEF-H1, that mediate rocaglate cytotoxicity in cancer cells. As a proof of concept, GEF-H1 activates RHOA, leading to increased JNK phosphorylation and apoptotic signaling resulting in reduced cell viability.

    Journal: Cell reports

    Article Title: Proteomics reveal cap-dependent translation inhibitors remodel the translation machinery and translatome

    doi: 10.1016/j.celrep.2021.109806

    Figure Lengend Snippet: Existing studies frame rocaglates as pure eIF4A/translation inhibitors. This study conceptually redefines rocaglates as translation remodelers that reprogram both the translation machinery, e.g., increasing eEF1ε1 translational activity, as well as the translatome, including the upregulation of numerous proteins, e.g., GEF-H1, that mediate rocaglate cytotoxicity in cancer cells. As a proof of concept, GEF-H1 activates RHOA, leading to increased JNK phosphorylation and apoptotic signaling resulting in reduced cell viability.

    Article Snippet: eEF1ε1 , Proteintech , Cat#10805-1-AP; RRID:AB_2097140.

    Techniques: Activity Assay, Phospho-proteomics

    KEY RESOURCES TABLE

    Journal: Cell reports

    Article Title: Proteomics reveal cap-dependent translation inhibitors remodel the translation machinery and translatome

    doi: 10.1016/j.celrep.2021.109806

    Figure Lengend Snippet: KEY RESOURCES TABLE

    Article Snippet: eEF1ε1 , Proteintech , Cat#10805-1-AP; RRID:AB_2097140.

    Techniques: Plasmid Preparation, Derivative Assay, Recombinant, Protease Inhibitor, cDNA Synthesis, SYBR Green Assay, Mass Spectrometry, Construct, Software

    The expression of EEF1E1 in HCC. (A) Comparing the expression of EEF1E1 in cancer and normal. (B) Comparing the expression of EEF1E1 in cancer and paracancerous. (C) The expression of EEF1E1 in HCC from Human protein Atlas.

    Journal: Frontiers in Oncology

    Article Title: A Novel HCC Prognosis Predictor EEF1E1 Is Related to Immune Infiltration and May Be Involved in EEF1E1/ATM/p53 Signaling

    doi: 10.3389/fonc.2021.700972

    Figure Lengend Snippet: The expression of EEF1E1 in HCC. (A) Comparing the expression of EEF1E1 in cancer and normal. (B) Comparing the expression of EEF1E1 in cancer and paracancerous. (C) The expression of EEF1E1 in HCC from Human protein Atlas.

    Article Snippet: The immunohistochemistry of EEF1E1 expression in HCC was downloaded from Human Protein Atlas ( ) ( http://www.proteinatlas.org ).

    Techniques: Expressing